COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

UC San Diego School of Medicine Names New Division Chief for Gastroenterology

 

August 23, 2010  |  

William Sandborn, MD, has been named the Division Chief for Gastroenterology in the University of California, San Diego Department of Medicine pending UCSD campus approval of his faculty appointment.  Currently Vice Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, Minnesota, Sandborn is expected to begin at UC San Diego School of Medicine at the end of the year.

William Sanborn

William Sandborn, MD

After medical school and an internal medicine residency at Loma Linda University, Sandborn completed a gastroenterology fellowship at the Mayo Clinic in 1993. In addition to serving as vice chair, he is the Dorothy A. Adair Professor of Medicine at Mayo Clinic College of Medicine and Associate Dean of Research for Intellectual Property and Industry Relations at Mayo Clinic. 

Sandborn has published more 340 peer reviewed articles, including articles in the New England Journal of Medicine, The Lancet, JAMA, The Annals of Internal Medicine, and the journal Gastroenterology. His research interests are clinical trials and clinical pharmacology related to inflammatory bowel disease. He is a key thought leader in the treatment of inflammatory bowel disease and has a large clinical practice in patients with these challenging illnesses.

# #  # 

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu


Related Specialties

Gastroenterology



Media Contact

Share This Article


Related News

7/23/2021
Senate President Pro Tempore Toni Atkins visited UC San Diego Medical Center today to recognize a $30 million allocation in the 2021-2022 California state budget that will support the redevelopment of ...
7/16/2021
Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus ...
7/15/2021
Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.
7/12/2021
UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human dise ...



Follow Us